These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
561 related articles for article (PubMed ID: 32525601)
1. Serum small extracellular vesicle-derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma. Kim SS; Baek GO; Ahn HR; Sung S; Seo CW; Cho HJ; Nam SW; Cheong JY; Eun JW Mol Oncol; 2020 Oct; 14(10):2646-2659. PubMed ID: 32525601 [TBL] [Abstract][Full Text] [Related]
2. Early detection of hepatocellular carcinoma via liquid biopsy: panel of small extracellular vesicle-derived long noncoding RNAs identified as markers. Kim SS; Baek GO; Son JA; Ahn HR; Yoon MK; Cho HJ; Yoon JH; Nam SW; Cheong JY; Eun JW Mol Oncol; 2021 Oct; 15(10):2715-2731. PubMed ID: 34185961 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic utility of plasma lncRNA small nucleolar RNA host gene 1 in patients with hepatocellular carcinoma. Gao S; Xu X; Wang Y; Zhang W; Wang X Mol Med Rep; 2018 Sep; 18(3):3305-3313. PubMed ID: 30066898 [TBL] [Abstract][Full Text] [Related]
4. A Circulating Long Noncoding RNA Panel Serves as a Diagnostic Marker for Hepatocellular Carcinoma. Huang J; Zheng Y; Xiao X; Liu C; Lin J; Zheng S; Yang B; Ou Q Dis Markers; 2020; 2020():5417598. PubMed ID: 32733618 [TBL] [Abstract][Full Text] [Related]
5. Serum exosomal long noncoding RNAs lnc-FAM72D-3 and lnc-EPC1-4 as diagnostic biomarkers for hepatocellular carcinoma. Yao Z; Jia C; Tai Y; Liang H; Zhong Z; Xiong Z; Deng M; Zhang Q Aging (Albany NY); 2020 Jun; 12(12):11843-11863. PubMed ID: 32554864 [TBL] [Abstract][Full Text] [Related]
6. Long Noncoding RNAs MALAT1 and HOTTIP Act as Serum Biomarkers for Hepatocellular Carcinoma. Bao H; Jiang Y; Wang N; Su H; Han X Cancer Control; 2024; 31():10732748241284821. PubMed ID: 39259658 [TBL] [Abstract][Full Text] [Related]
7. The long noncoding RNAs PVT1 and uc002mbe.2 in sera provide a new supplementary method for hepatocellular carcinoma diagnosis. Yu J; Han J; Zhang J; Li G; Liu H; Cui X; Xu Y; Li T; Liu J; Wang C Medicine (Baltimore); 2016 Aug; 95(31):e4436. PubMed ID: 27495068 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma. Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394 [TBL] [Abstract][Full Text] [Related]
9. Low expression of long noncoding RNA CTC-297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma. Zhu S; Huang X; Zhang K; Tan W; Lin Z; He Q; Chen Y; Shang C Cancer Med; 2019 Dec; 8(18):7679-7692. PubMed ID: 31674731 [TBL] [Abstract][Full Text] [Related]
10. Circulating LncRNAs Serve as Diagnostic Markers for Hepatocellular Carcinoma. Yuan W; Sun Y; Liu L; Zhou B; Wang S; Gu D Cell Physiol Biochem; 2017; 44(1):125-132. PubMed ID: 29130980 [TBL] [Abstract][Full Text] [Related]
11. Identification of long non-coding RNA Luo P; Liang C; Zhang X; Liu X; Wang Y; Wu M; Feng X; Tu J Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29559565 [TBL] [Abstract][Full Text] [Related]
12. lncRNA-D16366 Is a Potential Biomarker for Diagnosis and Prognosis of Hepatocellular Carcinoma. Chao Y; Zhou D Med Sci Monit; 2019 Sep; 25():6581-6586. PubMed ID: 31475695 [TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA MyD88 functions as a promising diagnostic biomarker in hepatocellular carcinoma. Wang Z; Gao P; Sun W; Rehman AU; Jiang J; Xu S; Xue C; Zhu C; Qin X Front Endocrinol (Lausanne); 2023; 14():938102. PubMed ID: 36793272 [TBL] [Abstract][Full Text] [Related]
14. RNA sequencing of plasma exosomes revealed novel functional long noncoding RNAs in hepatocellular carcinoma. Huang X; Sun L; Wen S; Deng D; Wan F; He X; Tian L; Liang L; Wei C; Gao K; Fu Q; Li Y; Jiang J; Zhai R; He M Cancer Sci; 2020 Sep; 111(9):3338-3349. PubMed ID: 32506598 [TBL] [Abstract][Full Text] [Related]
15. Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma. Zuo D; Chen L; Liu X; Wang X; Xi Q; Luo Y; Zhang N; Guo H Tumour Biol; 2016 May; 37(5):6539-49. PubMed ID: 26637228 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic Potential of the Serum lncRNAs HOTAIR, BRM and ICR for Hepatocellular Carcinoma. Lou ZH; Xu KY; Qiao L; Su XQ; Ou-Yang Y; Miao LB; Liu F; Wang Y; Fu A; Ren XH; Huang JS; Li ZY; Bao JF Front Biosci (Landmark Ed); 2022 Sep; 27(9):264. PubMed ID: 36224021 [TBL] [Abstract][Full Text] [Related]
17. Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma. Kamel MM; Matboli M; Sallam M; Montasser IF; Saad AS; El-Tawdi AHF Transl Res; 2016 Feb; 168():134-145. PubMed ID: 26551349 [TBL] [Abstract][Full Text] [Related]
18. Down-regulation of long non-coding RNA GAS5-AS1 and its prognostic and diagnostic significance in hepatocellular carcinoma. Wang Y; Jing W; Ma W; Liang C; Chai H; Tu J Cancer Biomark; 2018; 22(2):227-236. PubMed ID: 29660898 [TBL] [Abstract][Full Text] [Related]
19. Serum LncRNAs Profiles Serve as Novel Potential Biomarkers for the Diagnosis of HBV-Positive Hepatocellular Carcinoma. Wang K; Guo WX; Li N; Gao CF; Shi J; Tang YF; Shen F; Wu MC; Liu SR; Cheng SQ PLoS One; 2015; 10(12):e0144934. PubMed ID: 26674525 [TBL] [Abstract][Full Text] [Related]
20. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]